Doctors of the oncological center Blokhin said about the low quality of Russian generics

Doctors of the oncological center Blokhin said about the low quality of generics used in the suppression of tumor

The management of the National medical research centre (SMRC) of Oncology. N. N. Blokhin believes that several Russian generics used in antitumor treatment and supportive therapy of low efficiency. RBC reports, citing a memo signed by the Deputy Director of SMRC for research and clinical work Svetlana Varfolomeeva. She was sent in response to the request, the specialized publication “Farmvestnik”. The authenticity of the document was confirmed by the press service of the SMRC.

The note listed trade names and manufacturers of substandard medicines, their active substance.

Claims the SMRC is also Russian to the generic because of side effects.

The press service of the SMRC Blokhin said that now with the support of the Ministry of health and management center “all indicated in the text of the questions permitted.”

Earlier, the members of the Institute of pediatric Oncology and Hematology, part of the structure of the centre, demanded the dismissal of the Varfolomeeva and said about the problems. The Commission found no violations. The press service of the SMRC Blokhin announced the dismissal of nine employees, adding that in their place came new people.

© 2019, paradox. All rights reserved.